These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35600409)

  • 1. Comprehensive Analysis of 29,464 Cancer Cases and 35,858 Controls to Investigate the Effect of the Cytotoxic T-Lymphocyte Antigen 4 Gene rs231775 A/G Polymorphism on Cancer Risk.
    Wan H; Zhou H; Feng Y; Chen Y; Zhu L; Mi Y
    Front Oncol; 2022; 12():878507. PubMed ID: 35600409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CTLA-4 (+49 A/G) polymorphism with susceptibility to autoimmune diseases: A meta-analysis with trial sequential analysis.
    Yu L; Shao M; Zhou T; Xie H; Wang F; Kong J; Xu S; Shuai Z; Pan F
    Int Immunopharmacol; 2021 Jul; 96():107617. PubMed ID: 33866246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association of CTLA-4 rs231775 and rs3087243 Polymorphisms with Latent Autoimmune Diabetes in Adults: A Meta-Analysis.
    Pang H; Luo S; Huang G; Li X; Xie Z; Zhou Z
    Biochem Genet; 2022 Aug; 60(4):1222-1235. PubMed ID: 34822071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between cytotoxic T-lymphocyte-associated antigen 4 gene polymorphisms and diabetes mellitus: a meta-analysis of 76 case-control studies.
    Chen M; Li S
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988065
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies.
    Fang M; Huang W; Mo D; Zhao W; Huang R
    Cell Physiol Biochem; 2018; 47(1):414-427. PubMed ID: 29794444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the cytotoxic T-lymphocyte associated antigen-4 rs231775 A/G polymorphism on cancer risk.
    Pan H; Shi Z; Gao L; Zhang L; Wei S; Chen Y; Lu C; Wang J; Zuo L; Zhang L
    Heliyon; 2023 Dec; 9(12):e23164. PubMed ID: 38144286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA-4 polymorphisms and predisposition to digestive system malignancies: a meta-analysis of 31 published studies.
    Li J; Wang W; Sun Y; Zhu Y
    World J Surg Oncol; 2020 Mar; 18(1):55. PubMed ID: 32178688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between CTLA-4 +49 A/G (rs231775) polymorphism and cancer risk: a meta-analysis based on 52 case-control studies.
    Wang L; Jiang Z; Qiu H; Tang W; Duan T; Wang L
    Int J Clin Exp Med; 2015; 8(5):6835-51. PubMed ID: 26221222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association among cytotoxic T-lymphocyte antigen 4 gene, rs231775 polymorphism, and recurrent pregnancy loss risk.
    Song Y; Chen Y; Xu Q
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30578376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA-4 polymorphisms associate with breast cancer susceptibility in Asians: a meta-analysis.
    Dai Z; Tian T; Wang M; Liu X; Lin S; Yang P; Liu K; Zheng Y; Xu P; Liu M; Yang X; Dai Z
    PeerJ; 2017; 5():e2815. PubMed ID: 28097051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA-4 +49 G/A Polymorphism Confers Autoimmune Disease Risk: An Updated Meta-Analysis.
    Wang K; Zhu Q; Lu Y; Lu H; Zhang F; Wang X; Fan Y
    Genet Test Mol Biomarkers; 2017 Apr; 21(4):222-227. PubMed ID: 28384040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between cytotoxic T-lymphocyte antigen-4 +49A/G polymorphism and colorectal cancer risk: a meta-analysis.
    He L; Deng T; Luo HS
    Int J Clin Exp Med; 2015; 8(3):3752-60. PubMed ID: 26064271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Cytotoxic T-lymphocyte antigen 4 (CTLA-4) +49 G>A (rs231775) polymorphism and esophageal cancer: from a case-control study to a meta-analysis.
    Liu C; Wang Y; Jiang H; Tang W; Chen S; Kang M; Dong C; Gu H
    Int J Clin Exp Med; 2015; 8(10):17664-73. PubMed ID: 26770356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis: the relationship between CTLA-4 +49 A/G polymorphism and primary biliary cirrhosis and type I autoimmune hepatitis.
    Eskandari-Nasab E; Tahmasebi A; Hashemi M
    Immunol Invest; 2015; 44(4):331-48. PubMed ID: 25942345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cytotoxic T-lymphocyte antigen-4, TNF-alpha polymorphisms on osteosarcoma: evidences from a meta-analysis.
    Liu J; Wang J; Jiang W; Tang Y
    Chin J Cancer Res; 2013 Dec; 25(6):671-8. PubMed ID: 24385694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis: A meta-analysis.
    Zhao JJ; Wang D; Yao H; Sun DW; Li HY
    World J Gastroenterol; 2015 Sep; 21(34):10025-40. PubMed ID: 26379408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association Between
    Liu W; Yang Z; Chen Y; Yang H; Wan X; Zhou X; Liu R; Zhang Y
    Front Med (Lausanne); 2021; 8():598076. PubMed ID: 33604347
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between
    Zhou C; Gao S; Yuan X; Shu Z; Li S; Sun X; Xiao J; Liu H
    Aging (Albany NY); 2021 Aug; 13(15):19397-19414. PubMed ID: 34339393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of Association between CTLA-4 Gene Polymorphisms and Colorectal Cancers in Saudi Patients.
    Al-Harbi N; Abdulla MH; Vaali-Mohammed MA; Bin Traiki T; Alswayyed M; Al-Obeed O; Abid I; Al-Omar S; Mansour L
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cytotoxic T-lymphocyte antigen 4 rs231775 gene polymorphism with colorectal cancer risk.
    Zhang Y; Zhang S; Xia W; Dong Z
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S526-S532. PubMed ID: 29970719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.